TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
UFPT

UFP Technologies Inc

Healthcare · Medical Devices

281.70$ +1.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios UFPT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
29.8 29.5 40.8 41.3 45.4 32.3 24.7 28.3 23.1 25.4 22.0 28.6
3.2 3.3 4.8 4.9 5.3 3.8 2.9 3.2 2.6 2.9 2.5 3.3
4.6 4.6 6.6 6.6 7.5 5.6 4.3 4.9 3.8 4.1 3.4 4.5
3.3 3.4 4.9 5.0 5.8 4.1 3.2 3.5 2.8 3.1 2.7 3.5
19.3 19.7 27.3 28.1 31.6 21.8 16.7 18.2 15.0 16.0 14.0 18.9
34.8 43.0 48.5 47.5 54.1 33.5 26.6 26.2 17.8 21.9 21.7 33.6
2.9% 2.3% 2.1% 2.1% 1.8% 3.0% 3.8% 3.8% 5.6% 4.6% 4.6% 3.0%
Margins
28.1% 28.1% 27.9% 28.0% 28.3% 29.1% 29.0% 28.8% 28.5% 28.3% 28.4% 28.5%
14.3% 14.4% 14.9% 14.8% 15.5% 16.0% 16.1% 16.1% 15.6% 15.3% 15.2% 15.2%
10.7% 11.2% 11.8% 11.9% 11.7% 11.7% 11.6% 11.4% 11.2% 11.3% 11.3% 11.4%
9.2% 7.7% 9.9% 10.3% 9.8% 11.3% 10.8% 12.3% 14.6% 13.1% 11.4% 9.7%
Returns
15.3% 15.7% 16.2% 16.0% 16.5% 17.2% 17.6% 17.4% 16.6% 16.1% 15.6% 15.6%
10.4% 11.1% 11.7% 11.7% 8.5% 9.4% 9.9% 10.6% 10.3% 10.3% 10.2% 10.6%
Balance Sheet & Debt
40 30 26 22 200 180 173 153 133 120 123 113
0.6 0.4 0.4 0.3 2.4 1.9 1.7 1.4 1.2 1.0 1.1 1.0
68.1% 70.8% 72.4% 73.4% 51.5% 54.5% 56.1% 60.7% 61.9% 63.7% 65.0% 67.8%
0.2 0.1 0.1 0.1 0.7 0.6 0.5 0.4 0.4 0.3 0.3 0.3
Per Share
5.42 5.83 6.19 6.39 6.98 7.57 8.16 8.63 8.63 8.75 8.80 9.27
50.57 51.88 52.65 53.85 59.42 64.72 70.42 75.72 76.86 77.24 78.07 81.02
35.33 37.10 38.13 40.01 42.35 43.98 46.38 49.59 51.92 54.32 56.27 59.32
4.65 4.00 5.20 5.55 5.85 7.31 7.59 9.33 11.24 10.12 8.90 7.88

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?